Notice of Change to Add Responsiveness Criteria and Further Clarify Clinical Trials Allowed in PAR-20-316 "Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)"

Notice NOT-NS-21-076 from the NIH Guide for Grants and Contracts
Source: NIH Funding Opportunities (Notices, PA, RFA) - Category: Research Source Type: funding